Temporal lobe pleomorphic xanthoastrocytoma and acquired BRAF mutation in an adolescent with the constitutional 22q11.2 deletion syndrome

Journal of Neuro-Oncology

Volumn 102, Issue 3, 2011, Pages 509-514

  Murray, Jeffrey C ^a   Donahue, David J ^a   Malik, Saleem I ^a   Dzurik, Yvette B ^a   Braly, Emily Z ^a   Dougherty, Margaret J ^b   Eaton, Katherine W ^b   Biegel, Jaclyn A ^b  

^a Cook Children's Medical Center ^*  (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

22q11.2 deletion syndrome; BRAF; DiGeorge syndrome; Pleomorphic xanthoastrocytoma; SNP array

Indexed keywords

B RAF KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B;

ADOLESCENT; ARTICLE; BRAF GENE; CASE REPORT; CHROMOSOME 21; CHROMOSOME DELETION 22Q11; DIGEORGE SYNDROME; GENE DOSAGE; GENE LOCUS; GENE MUTATION; GENETIC GAIN; HETEROZYGOSITY LOSS; HISTOLOGY; HOMOZYGOSITY; HUMAN; MALE; MOLECULAR GENETICS; NEUROEPITHELIOMA; NEUROSURGERY; ONCOGENE; PLEOMORPHIC XANTHOASTROCYTOMA; SINGLE NUCLEOTIDE POLYMORPHISM; TEMPORAL LOBE; VELOCARDIOFACIAL SYNDROME;

ADOLESCENT; ASTROCYTOMA; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 22; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF;

EID: 79958184750     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0350-2     Document Type: Article

References (21)

1. DiGeorge AM (1968) Congenital absence of the thymus and its immunologic consequences: concurrence with congenital hypoparathyroidism. IV(1). White Plains, NY: March of Dimes-Birth Defects Foundation:116-121
2. Emanuel BS, McDonald-McGinn D, Saitta SC, Zackai EH (2001) The 22q11.2 deletion syndrome. Adv Pediatr 48:39-73
3. Shaikh TH, Kurahashi H, Saitta SC, O'Hare AM, Hu P, Roe BA, Driscoll DA, McDonald-McGinn DM, Zackai EH, Budarf ML, Emanuel BS (2000) Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum Mol Genet 9:489-501 (Pubitemid 30154007)
4. Oskarsdottir S, Vujic M, Fasth A (2004) Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch Dis Child 89(2):148-151 (Pubitemid 38168974)
5. McDonald-McGinn DM, Reilly A, Wallgren-Pettersson C, Hoyme HE, Yang SP, Adam MP, Zackie EH, Sullivan KE (2006) Malignancy in chromosome 22q11.2 deletion syndrome (Digeorge syndrome/velocardiofacial syndrome). Am J Med Genet 140A:906-909
6. Jalali GR, Vorstman JA, Errami A, Vijzelaar R, Biegel J, Shaikh T, Emanuel BS (2008) Detailed analysis of 22q11.2 with a high density MLPA probe set. Hum Mutat 29(3):433-440 (Pubitemid 351364946)
7. Jackson EM, Shaikh TH, Gururangan S, Jones MC, Malkin D, Nikkel SM, Zuppan CW, Wainwright LM, Zhang F, Biegel JA (2007) High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor. Hum Genet 122:117-127 (Pubitemid 47241777)
8. Scattone A, Caruso G, Marzullo A, Piscitelli D et al (2003) Neoplastic disease and deletion 22q11.2: a multicentric study and report of two cases. Pediatr Pathol Mol Med 22:323-341 (Pubitemid 37092533)
9. Jackson EM, Sievert AJ, Gai X, Hakonarson H, Judkins AR, Tooke L, Perin JC, Xie H, Shaikh TH, Biegel JA (2009) Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors. Clin Cancer Res 15(6):1923-1930
10. Dougherty MJ, Santi M, Brose MS, Ma C, Resnick AC, Sievert AJ, Storm PB, Biegel JA (2010) Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas. Neuro Oncol doi: 10.1093/neuonc/noq007
11. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) (2007) W.H.O. Classification of tumors of the central nervous system. IARC, Lyon
12. Kepes JJ, Rubinstein LJ, Ansbacher L, Schreiber DJ (1989) Histopathological features of recurrent pleomorphic xanthoastrocytomas: Further corroboration of the glial nature of the neoplasm: A study of 3 cases. Acta Neuropathol 78:585-593 (Pubitemid 19251312)
13. Fouladi M, Jenkins J, Burger P, Langston J, Merchant T, Heideman R, Thompson S, Sanford A, Kun L, Gajjar A (2001) Pleomorphic xanthoastrocytoma: favorable outcome after complete surgical resection. Neuro-Oncol 3:184-192 (Pubitemid 33674110)
14. ARF/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas. Oncogene 26:1088-1097
15. Davies H, Bignelli GR, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949-954 (Pubitemid 34716871)
16. E600 in benign and malignant human tumors. Oncogene 27:877-895
17. Sievert AJ, Jackson EM, Gai X et al (2009) Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene. Brain Pathol 19(3):449-458
18. Jones DTW, Kocialkowski S, Liu L et al (2008) Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68:8673-8677
19. Forshew T, Tatvossian RG, Lawson ARJ et al (2009) Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol 218(2):172-181
20. Sawyer JR, Roloson GJ, Chadduck WM, Boop FA (1991) Cytogenetic findings in a pleomorphic xanthoastrocytoma. Cancer Genet Cytogenet 55:225-230
21. Yin X, Hui AB, Lion EC, Ding M, Chang AR, Ng H (2002) Genetic imbalances in pleomorphic xanthoastrocytoma detected by comparative genomic hybridization and literature review. Cancer Genet Cytogenet 132:14-19 (Pubitemid 34136044)